Volume 34 Number 25 June 25 - July 2, 2015
Antimicrobials/ Vaccines/ Interventions
It's all about those bases: The need for incorporating parasite genetic heterogeneity into the development of schistosome vaccines.
Gleichsner AM et al. PLoS Negl Trop Dis 2015 Jun (6) e0003805
Gleichsner AM et al. PLoS Negl Trop Dis 2015 Jun (6) e0003805
Protection against Shiga toxigenic Escherichia coli by non-GMO receptor-mimic bacterial ghosts.
Paton AW et al. Infect. Immun. 2015 Jun 22.
Paton AW et al. Infect. Immun. 2015 Jun 22.
Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings.
Phillips A et al. PLoS ONE 2014 (10) e109148
Phillips A et al. PLoS ONE 2014 (10) e109148
Genomics reveals the worldwide distribution of multidrug-resistant serotype 6E pneumococci.
van Tonder AJ et al. J. Clin. Microbiol. 2015 Jul (7) 2271-85
van Tonder AJ et al. J. Clin. Microbiol. 2015 Jul (7) 2271-85
Assessing the paradox between transmitted and acquired HIV type 1 drug resistance mutations in the Swiss HIV cohort study from 1998 to 2012.
Yang Wan-Lin et al. J. Infect. Dis. 2015 Jul 1. (1) 28-38
Yang Wan-Lin et al. J. Infect. Dis. 2015 Jul 1. (1) 28-38
No hay comentarios:
Publicar un comentario